SOD2 and familial pancreatic carcinoma: Pterostilbene's ability to increase antioxidant activity by altering expression and enzymatic activity of MnSOD contributes to its credence as an anticancer agent because numerous studies show that pancreatic cancer cells have decreased expression of MnSOD when compared to normal cells and overexpression of MnSOD correlates with decreased pancreatic tumor volume [65–68].